Of the 36 CDX2-low CRCs, 13.9% were poorly differentiated adenocarcinoma, which is quite high when compared with only 3.6% in the CDX2-high CRCs (P = 0.02; Table 1). This evidence concerns the gene CDX2 and adenocarcinoma.